23andMe independent board resigns in feud over CEO Anne Wojcicki’s plan to take company private
All seven of 23andMe’s independent board members resigned in a stinging rebuke to a proposal by CEO Anne Wojcicki’s plans to to take the company private. Wojcicki, who has been trying to take the company private since April, proposed to acquire all outstanding shares of 23andMe not owned by her or her affiliates for $0.40 per share, in July.
The board of Anne Wojcicki's genetic-testing company resigned earlier this week. This founder thinks he has a plan to save ...
Me's entire board of directors resigned over cofounder and CEO Anne Wojcicki's ongoing plan to take it private.
The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...
Following a monthslong battle over CEO Anne Wojcicki’s plans to take 23andMe private, all seven independent members of its board resigned en masse Tuesday. The move is almost certainly the final ...
By letter dated August 2, 2024, a Special Committee of the Board of Directors of 23andMe rejected that offer, noting that it "provide [d] no premium to the closing price per share on Wednesday, July ...
Good morning, Broadsheet readers! All board members resigned from Anne Wojcicki’s 23andMe, Teresa Ribera will likely become Europe’s new antitrust chief, and Midi Health raises $5 million from a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback